THE LATEST FROM RAKOVINA
Discovery in motion.
Rakovina Therapeutics Announces Second Upsizing of Private Placement
DOWNLOAD All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 19, 2024 - Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on...
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
Download PDF All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 20, 2024 - Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on...
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
DOWNLOAD pDF All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to...
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
DOWNLOAD PDF FOR IMMEDIATE RELEASE All monetary figures listed in Canadian Dollars. May 24, 2024, Vancouver, British Columbia-- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
Download PDF All monetary figures listed in Canadian Dollars. Vancouver, British Columbia, May 23, 2024 - Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies...
